Bharat Biotech, CSIR, Others Join Hands To Upscale Indigenous Vaccines

Vaccine developers Bharat Biotech International, Biovet and Sapigen Biologix on March 29 collaborated with CSIR-Indian Institute of Chemical Technology to enhance indigenous vaccines and health care solutions. Reportedly, CSIR-IICT will be funded by the pharmaceutical firms to innovate and develop affordable healthcare technologies for humans and animals. Initiated under the Aatmanirbhar Bharat Vision, the master collaborative agreement aims to strengthen the innovation ecosystem by pooling the expertise of CSIR labs.